91 related articles for article (PubMed ID: 21541567)
1. Novel cellular markers in breast cancer.
Bhui A; Bureau J; Abbas A; Mondal A; Scherrer K; Kurkure A; Therwath A
Int J Oncol; 1996 Oct; 9(4):669-77. PubMed ID: 21541567
[TBL] [Abstract][Full Text] [Related]
2. Proliferation markers and cell cycle associated expression of prosomes in breast cancers of Parsis and non-Parsis.
Bhui A; Bureau J; Parikh V; Kukreti R; Scherrer K; Mondal A; Therwath A
Int J Oncol; 1997 Aug; 11(2):297-304. PubMed ID: 21528214
[TBL] [Abstract][Full Text] [Related]
3. Increased prosomal proteins in breast cancer cells and in neighboring normal cells in Parsi and non-Parsi populations.
Bhui-Kaur A; Therwath A; Henry L; Chiesa J; Kurkure A; Scherrer K; Bureau JP
J Cancer Res Clin Oncol; 1998; 124(2):117-26. PubMed ID: 9654195
[TBL] [Abstract][Full Text] [Related]
4. Expression of cell surface glycoprotein CD44 and integrins in breast cancers among Indian women.
Menon MM; Thakur R; Simha MR; Kurkure AP; Kenkare UW; Doctor VM
Tumori; 1998; 84(5):589-94. PubMed ID: 9862522
[TBL] [Abstract][Full Text] [Related]
5. p53 alterations in breast cancer of the Parsi ethnic group.
Abbas A; Kukreti R; Naik S; Therwath A
Int J Oncol; 1997 Feb; 10(2):401-4. PubMed ID: 21533391
[TBL] [Abstract][Full Text] [Related]
6. An Assessment of Cancer Incidence Patterns in Parsi and Non Parsi Populations, Greater Mumbai.
Yeole BB; Kurkure A; Advani S; Lizzy S
Asian Pac J Cancer Prev; 2001; 2(4):293-298. PubMed ID: 12718621
[TBL] [Abstract][Full Text] [Related]
7. Differences observed in the site incidence of cancer, between the Parsi community and the total population of greater Bombay: a critical appraisal.
Jussawalla DJ; Deshpande VA; Haenszel W; Natekar MV
Br J Cancer; 1970 Mar; 24(1):56-66. PubMed ID: 5428617
[TBL] [Abstract][Full Text] [Related]
8. Changes in the amount and distribution of prosomal subunits during the differentiation of U937 myeloid cells: high expression of p23K.
Henry L; Baz A; Château MT; Scherrer K; Bureau JP
Cell Prolif; 1996 Nov; 29(11):589-607. PubMed ID: 9105416
[TBL] [Abstract][Full Text] [Related]
9. "Like sugar in milk": reconstructing the genetic history of the Parsi population.
Chaubey G; Ayub Q; Rai N; Prakash S; Mushrif-Tripathy V; Mezzavilla M; Pathak AK; Tamang R; Firasat S; Reidla M; Karmin M; Rani DS; Reddy AG; Parik J; Metspalu E; Rootsi S; Dalal K; Khaliq S; Mehdi SQ; Singh L; Metspalu M; Kivisild T; Tyler-Smith C; Villems R; Thangaraj K
Genome Biol; 2017 Jun; 18(1):110. PubMed ID: 28615043
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer and religion in greater Bombay women: an epidemiological study of 2130 women over a 9-year period.
Jussawalla DJ; Jain DK
Br J Cancer; 1977 Nov; 36(5):634-8. PubMed ID: 597382
[TBL] [Abstract][Full Text] [Related]
11. Models and tests of linkage and association studies of quantitative trait locus for multi-allele marker Loci.
Fan R; Floros J; Xiong M
Hum Hered; 2002; 53(3):130-45. PubMed ID: 12145549
[TBL] [Abstract][Full Text] [Related]
12. Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.
Dawson AE; Norton JA; Weinberg DS
Am J Pathol; 1990 May; 136(5):1115-24. PubMed ID: 1972000
[TBL] [Abstract][Full Text] [Related]
13. Structural status of the int loci in women showing high incidence of breast cancer.
Abbas A; Amar L; Kurkure A; Therwath A
Int J Oncol; 1996 Oct; 9(4):795-800. PubMed ID: 21541585
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological features and prognosis of breast cancer in different religious communities in India.
Badwe RA; Gangawal S; Mittra I; Desai PB
Indian J Cancer; 1990 Dec; 27(4):220-8. PubMed ID: 2090578
[TBL] [Abstract][Full Text] [Related]
15. Variation in DNA polymorphisms of the short arm of the human X chromosome: genetic affinity of Parsi from western India.
al-Maghtheh M; Ray V; Mastana SS; Garralda MD; Bhattacharya SS; Papiha SS
Hum Hered; 1993; 43(4):239-43. PubMed ID: 8102115
[TBL] [Abstract][Full Text] [Related]
16. HLA analysis of the Parsi (Zoroastrian) population in Pakistan.
Mohyuddin A; Mehdi SQ
Tissue Antigens; 2005 Dec; 66(6):691-5. PubMed ID: 16305686
[TBL] [Abstract][Full Text] [Related]
17. Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry.
Ishikuro A; Dosaka-Akita H; Kato M; Fujino M; Isobe H; Miyamoto H; Inoue K; Kawakami Y
Cytometry; 1997 Aug; 30(4):186-91. PubMed ID: 9298837
[TBL] [Abstract][Full Text] [Related]
18. Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.
Schlotter CM; Tietze L; Vogt U; Heinsen CV; Hahn A
Horm Mol Biol Clin Investig; 2017 Sep; 32(2):. PubMed ID: 28937963
[TBL] [Abstract][Full Text] [Related]
19. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
Lellé RJ
Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
[TBL] [Abstract][Full Text] [Related]
20. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
